It is important to note that we observed a relationship with EV expressing neuroinflammatory damage markers (GFAP, MAP2, and CD200) and monocytes in the periphery in ART-treated HIV-infected individuals with cognitive impairment, suggesting the presence of a cross-talk between the periphery immune system and the brain during disease. This evidence concerns the gene GFAP and Cognitive impairment.